Medical Device News Magazine

EaglePicher Medical Power Introduces New Contego 440 mAh Lithium-ion Battery

New Contego® 440: An Implantable & Rechargeable Large-capacity, Small-footprint Cell Utilizing a Proven Chemistry that Has Extensive Cycling Data Across Multiple Medical Customers

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

EaglePicher® Medical Power, a division of EaglerPicher Technologies, announced today the launch of the all-new Contego® 440 mAh battery, an implantable grade, lightweight, and high-energy-density lithium-ion battery.

According to EaglePicher, the rechargeable off-the-shelf Contego 440 offers superior rate capability and cycle life and is manufactured in a certified ISO13405 facility.

The Contego 440 battery comes in a fully welded hermetically sealed stainless-steel case and can be used across a range of medical applications including neuromodulators, drug pumps, body fluid pumps, and cardiac monitors. The individual battery weighs just 19.1g and carries a voltage range of 3.0 to 4.1V. While the Contego 440 is available off-the-shelf, additional options include custom terminations, application-specific documentation for FDA submission, application-specific testing, custom markings, and custom packaging.

“We’re extremely pleased to introduce the Contego 440 as part of our growing line of mission-critical medical device batteries,” commented Chris Huntington, EaglePicher Medical Power’s President. “The team at EaglePicher Medical Power is committed to developing the latest technology innovations to fuel medical advancement, treatment protocols and improve quality of life. With the new Contego 440, we’ve succeeded in delivering more energy in a small, lightweight cell, while never compromising safety.”

EaglePicher has been at the forefront of implantable medical-grade power solutions for over 25 years. The electrochemistry used in Contego lithium-ion batteries, since 2004, is proven in multiple cell sizes and is remarkably robust, without experiencing a single field failure. Over time, demand has grown for batteries like the new Contego 440, which can do more with less of a physical footprint.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”